Subscribe to RSS
DOI: 10.1055/s-0044-1779657
Giant Cell Tumor of the Tendon Sheath of the Hand: Analysis of Factors Impacting Recurrence
Abstract
Background Giant cell tumors of the tendon sheath (GCTTS) of the hand are considered the second most common benign tumors of the hand after ganglion cysts. Excision biopsy is considered the standard treatment at present. They are notorious for having a very high rate of recurrence as given in many studies. Many factors are said to be associated with recurrence of the tumors. The goal of this study is to evaluate the long-term results of a series of 48 patients operated on at a single institute and to find out if there is any correlation between the proposed risk factors with recurrence.
Methods A retrospective analysis was done in cases of GCTTS operated on between 2015 and 2021. The patients were invited for follow-up for a minimum of 2 years, and the patient files were reviewed. Further data were collected at follow-up including recurrence, range of movement, sensation, skin necrosis, scarring, and digital neuropathy. A data analysis was done. The correlation between the proposed risk factors and recurrence was calculated with the Pearson correlation coefficient. A p-value of less than 0.05 was considered statistically significant.
Results During the 6 years, 48 patients were operated on. Recurrence was observed in eight patients (16%) at an average of 38.7 months from the time of surgery. Of the risk factors, tumors with satellite nodules and tumor adjacency to joint correlated significantly with recurrence. No complications were observed during follow-up.
Conclusion GCTTS of the hand has a high propensity to recur. The presence of satellite nodules and proximity to interphalangeal joints are two important risk factors for recurrence. Magnification during surgery ensures complete excision of the tumor and reduces the chance of recurrence.
Author Contributions
P.V.K. contributed to the study design, collection of data, data analysis, and writing of the manuscript. S.S.A. contributed to the study design, data analysis, operative procedure, and patient care. I.A. contributed to the study design, collection of data, data analysis, operative procedure, and patient care. I.K.S. and O.P. contributed to writing of the manuscript. Y.R.K. contributed to data collection.
Publication History
Article published online:
21 February 2024
© 2024. Association of Plastic Surgeons of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Monaghan H, Salter DM, Al-Nafussi A. Giant cell tumour of tendon sheath (localised nodular tenosynovitis): clinicopathological features of 71 cases. J Clin Pathol 2001; 54 (05) 404-407
- 2 Al-Qattan MM. Giant cell tumours of tendon sheath: classification and recurrence rate. J Hand Surg [Br] 2001; 26 (01) 72-75
- 3 Reilly KE, Stern PJ, Dale JA. Recurrent giant cell tumors of the tendon sheath. J Hand Surg Am 1999; 24 (06) 1298-1302
- 4 Middleton WD, Patel V, Teefey SA, Boyer MI. Giant cell tumors of the tendon sheath: analysis of sonographic findings. AJR Am J Roentgenol 2004; 183 (02) 337-339
- 5 West RB, Rubin BP, Miller MA. et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A 2006; 103 (03) 690-695
- 6 Kitagawa Y, Ito H, Yokoyama M, Sawaizumi T, Maeda S. The effect of cellular proliferative activity on recurrence and local tumour extent of localized giant cell tumour of tendon sheath. J Hand Surg [Br] 2004; 29 (06) 604-607
- 7 Ozben H, Coskun T. Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases. BMC Musculoskelet Disord 2019; 20 (01) 457
- 8 Lowyck H, De Smet L. Recurrence rate of giant cell tumors of the tendon sheath. Eur J Plast Surg 2006; 28 (06) 385-388
- 9 Kotwal PP, Gupta V, Malhotra R. Giant-cell tumour of the tendon sheath. Is radiotherapy indicated to prevent recurrence after surgery?. J Bone Joint Surg Br 2000; 82 (04) 571-573
- 10 Darwish FM, Haddad WH. Giant cell tumour of tendon sheath: experience with 52 cases. Singapore Med J 2008; 49 (11) 879-882
- 11 Williams J, Hodari A, Janevski P, Siddiqui A. Recurrence of giant cell tumors in the hand: a prospective study. J Hand Surg Am 2010; 35 (03) 451-456
- 12 Fotiadis E, Papadopoulos A, Svarnas T, Akritopoulos P, Sachinis NP, Chalidis BE. Giant cell tumour of tendon sheath of the digits. A systematic review. Hand (N Y) 2011; 6 (03) 244-249
- 13 Ikeda K, Osamura N, Tomita K. Giant cell tumour in the tendon sheath of the hand: importance of the type of lesion. Scand J Plast Reconstr Surg Hand Surg 2007; 41 (03) 138-142
- 14 Grover R, Grobbelaar AO, Richman PI, Smith PJ. Measurement of invasive potential provides an accurate prognostic marker for giant cell tumour of tendon sheath. J Hand Surg [Br] 1998; 23 (06) 728-731
- 15 Siegel M, Bode L, Südkamp N. et al. Treatment, recurrence rates and follow-up of tenosynovial giant cell tumor (TGCT) of the foot and ankle: a systematic review and meta-analysis. PLoS One 2021; 16 (12) e0260795